Use of exogenous gangliosides for the preparation of a medicament for use in tumoral diseases as a protective factor against toxicity by antitumor drugs

摘要

The invention relates to the use of a mixture of gangliosides GM1, GD1a, GD1b and GT1b for the manufacture of a pharmaceutical composition for the prevention or the prophylactic treatment of general toxic effects or chronic neurotoxic effects caused by the subsequent administration of antineoplastic agents.